Loading code details...
Loading code details...
Encounter for follow-up examination after completed treatment for malignant neoplasm
Chapter 21: Factors influencing health status and contact with health services
From parent codes: Z00-Z99 (Chapter 21)
Additional notes from parent codes that apply to this code.
Chemotherapy Without Acute Leukemia As Secondary Diagnosis With Cc
Avg. Medicare Payment
$12,159
Chemotherapy Without Acute Leukemia As Secondary Diagnosis With Mcc
Avg. Medicare Payment
$27,886
Chemotherapy With Acute Leukemia As Secondary Diagnosis Or With High Dose Chemotherapy A
Avg. Medicare Payment
$50,344
Chemotherapy With Acute Leukemia As Secondary Diagnosis With Cc Or High Dose Chemotherap
Avg. Medicare Payment
$21,913
Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.r. Procedur
Avg. Medicare Payment
$25,173
Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Other Procedures Wi
Avg. Medicare Payment
$35,720
Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.r. Procedur
Avg. Medicare Payment
$15,673
Chemotherapy With Acute Leukemia As Secondary Diagnosis Without Cc/mcc
Avg. Medicare Payment
$12,772
Myeloproliferative Disorders Or Poorly Differentiated Neoplasms With Major O.r. Procedur
Avg. Medicare Payment
$65,885